MSB 2.89% $1.25 mesoblast limited

Dr. Michael Bowdish - Reflections on MSB's NIH Trial, page-141

  1. 1,566 Posts.
    lightbulb Created with Sketch. 13
    I can see a tweet from Aly D linking the blog, but no tweet directly from Michael Bowdish's twitter feed. I'm sorry to seem so doubtful but I honestly want some clarity.
    He also didn't refer to the Mesoblast product just that it was a trial...

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.